Evaluation of novel phosphoramidate ProTides of the 2′-fluoro derivatives of a potent anti-varicella zoster virus bicyclic nucleoside analogue

Antiviral Chemistry and Chemotherapy

Volumn 21, Issue 1, 2010, Pages 15-31

  Derudas, Marco ^a   Quintiliani, Maurizio ^a   Brancale, Andrea ^a   Andrei, Graciela ^b   Snoeck, Robert ^b   Balzarini, Jan ^b   McGuigan, Christopher ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CF 1743; FV 100; NUCLEOSIDE DERIVATIVE; PHOSPHORAMIDIC ACID DERIVATIVE; PROTIDE; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG MECHANISM; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SYNTHESIS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS; VIRUS STRAIN;

AMIDES; ANTIVIRAL AGENTS; CELL LINE; FLUORINE; HERPESVIRUS 3, HUMAN; MODELS, MOLECULAR; PHOSPHORIC ACIDS; PROTEIN CONFORMATION; PYRIMIDINE NUCLEOSIDES; THYMIDINE KINASE;

EID: 78751683938     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1661     Document Type: Article

References (29)

1. McGuigan C, Barucki H, Blewett S, et al. Highly potent and selective inhibition of varicella-zoster virus by bicyclic furo pyrimidine nucleosides bearing an aryl side chain. J Med Chem 2000; 43:4993-4997. (Pubitemid 32039020)
2. McGuigan C, Balzarini J. FV100 as a new approach for the possible treatment of varicella-zoster virus infection. J Antimicrob Chemother 2009; 64:671-673.
3. Brancale A, McGuigan C, Andrei G, Snoeck R, De Clercq E, Balzarini J. Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): the effect of a terminal halogen substitution in the side-chain. Bioorg Med Chem Lett 2000; 10:1215-1217. (Pubitemid 30345094)
4. Srinivasan S, McGuigan C, Andrei G, Snoeck R, De Clercq E, Balzarini J. Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): the effect of terminal unsaturation in the side chain. Bioorg Med Chem Lett 2001; 11:391-393. (Pubitemid 32115854)
5. McGuigan C, Bidet O, Derudas M, Andrei G, Snoeck R, Balzarini J. Alkenyl substituted bicyclic nucleoside analogues retain nanomolar potency against varicella zoster virus. Bioorg Med Chem 2009; 17:3025-3027.
6. Luoni G, McGuigan C, Andrei G, Snoeck R, De Clercq E, Balzarini J. Bicyclic nucleoside inhibitors of varicella-zoster virus: the effect of branching in the p-alkylphenyl side chain. Bioorg Med Chem Lett 2005; 15:3791-3796. (Pubitemid 41038980)
7. McGuigan C, Jukes A, Blewett S, et al. Halophenyl furanopyrimidines as potent and selective anti-VZV agents. Antivir Chem Chemother 2003; 14:165-170. (Pubitemid 37087256)
8. Luoni GM. The design, synthesis, and biological evaluation of novel nucleoside analogues as potential antiviral agents. PhD Thesis, Cardiff University, 2004.
9. McGuigan C, Pathirana RN, Jones G, et al. Anti-varicella-zoster virus bicyclic nucleosides: replacement of furo by pyrro base reduces antiviral potency. Antivir Chem Chemother 2000; 11:343-348. (Pubitemid 32011360)
10. Brancale A, McGuigan C, Algain B, et al. Bicyclic anti-VZV nucleosides: thieno analogues retain full antiviral activity. Bioorg Med Chem Lett 2001; 11:2507-2510. (Pubitemid 32823344)
11. Angell A, McGuigan C, Sevillano LG, et al. Bicyclic anti-VZV nucleosides: thieno analogues bearing an alkylphenyl side chain have reduced antiviral activity. Bioorg Med Chem Lett 2004; 14:2397-2399. (Pubitemid 38515673)
12. McGuigan C, Barucki H, Brancale A, et al. Fluorescent bicyclic furo pyrimidine deoxynucleoside analogues as potent and selective inhibitors of VZV and potential future drugs for the treatment of chickenpox and shingles. Drugs Future 2000; 25:1151-1161.
13. McGuigan C, Pathirana RN, Snoeck R, Andrei G, De Clercq E, Balzarini J. Discovery of a new family of inhibitors of human cytomegalovirus (HCMV) based upon lipophilic alkyl furano pyrimidine dideoxy nucleosides: action via a novel non-nucleosidic mechanism. J Med Chem 2004; 47:1847-1851.
14. Carangio A, McGuigan C, Andrei G, Snoeck R, De Clercq E, Balzarini J. Bicyclic nucleoside inhibitors of varicella-zoster virus: synthesis and biological evaluation of 2′,3′-dideoxy-3′-fluoro and 2′-deoxy-xylo derivatives. Nucleosides Nucleotides Nucleic Acids 2003; 22:935-937.
15. McGuigan C, Carangio A, Snoeck R, Andrei G, De Clercq E, Balzarini J. Synthesis and antiviral evaluation of some 3′-fluoro bicyclic nucleoside analogues. Nucleosides Nucleotides Nucleic Acids 2004; 23:1-5.
16. Luoni G, McGuigan C, Andrei G, Snoeck R, De Clercq E, Balzarini J. Bicyclic nucleoside inhibitors of varicella-zoster virus: 5′-chloro and 3′-chloro derivatives. Nucleosides Nucleotides Nucleic Acids 2003; 22:931-933. (Pubitemid 37139293)
17. Luoni GM, McGuigan C, Andrei G, Snoeck R, De Clercq E, Balzarini J. Bicyclic nucleoside inhibitors of varicella-zoster virus modified on the sugar moiety: 3′ and 5′ derivatives. Antivir Chem Chemother 2004; 15:333-341.
18. Janeba Z, Balzarini J, Andrei G, Snoeck R, De Clercq E, Robins MJ. Synthesis and biological evaluation of acyclic 3-[(2-hydroxyethoxy)methyl] analogues of antiviral furoand pyrrolo[2,3-d]pyrimidine nucleosides. J Med Chem 2005; 48:4690-4696.
19. Migliore MD, Zonta N, McGuigan C, et al. Synthesis and antiviral activity of the carbocyclic analogue of the highly potent and selective anti-VZV bicyclo furano pyrimidines. J Med Chem 2007; 50:6485-6492.
20. Sienaert R, Naesens l, Brancale A, De Clercq E, McGuigan C, Balzarini J. Specific recognition of the bicyclic pyrimidine nucleoside analogues, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase. Mol Pharmacol 2002; 61:249-254.
21. McGuigan C, Derudas M, Quintiliani M, et al. Fluorosugar analogues of the highly potent anti-VZV BCNAs. Bioorg Med Chem Lett 2009; 19:6264-6267.
22. Sienaert R, Andrei G, Snoeck R, De Clercq E, McGuigan C, Balzarini J. Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase. Biochem Biophys Res Commun 2004; 315:877-883. (Pubitemid 38249385)
23. Marquez VE, Hughes SH, Sei S, Agbaria R. The history of N-methanocarbathymidine: the investigation of a conformational concept leads to the discovery of a potent and selective nucleoside antiviral agent. Antiviral Res 2006; 71:268-275.
24. Marquez VE, Ben-Kasus T, Barchi JJ, Green KM, Nicklaus MC, Agbaria R. Experimental and structural evidence that herpes 1 kinase and cellular DNA polymerase(s) discriminate on the basis of sugar pucker. J Am Chem Soc 2004; 126:543-549. (Pubitemid 38084634)
25. Korb O, Stützle T, Exner TE. PLANTS: application of ant colony optimization to structure-based drug design. In Dorigo M, Gambardella LM, Birattari M, Martinoli A, Poli R, Stützle T (Editors). Ant colony optimization and swarm intelligence, lecture notes in computer science. Berlin/ Heidelberg: Springer 2006; pp. 247-258.
26. Asakura J, Robins MJ. Cerium(IV)-mediated halogenation at C-5 of uracil derivatives. J Org Chem 1990; 55:4928-4933. (Pubitemid 20269840)
27. Tann CH, Brodfuehrer PR, Brundidge SP. Sapino CJr, Howell HG. Fluorocarbohydrates in synthesis. An efficient synthesis of 1-(2-deoxy-2-fluoro- β-d-arabinofuranosyl)-5-iodouracil (β-FIAU) and 1-(2-deoxy-2-fluoro- β-darabinofuranosyl) thymine (β-FMAU). J Org Chem 1985; 50:3644-3647.
28. Kotra LP, Xiang Y, Newton MG, Schinazi RF, Cheng Y-C, Chu CK. Structure-activity relationships of 2′-deoxy-2′,2′-difluoro-L- erythro-pentofuranosyl nucleosides. J Med Chem 1997; 40:3635-3644.
29. Van Boom JH, Burgers PMJ, Crea R, Luyten WCMM, Vink ABJ, Reese CB. Phosphorylation of nucleoside derivatives with aryl phosphoramidochloridates. Tetrahedron 1975; 31:2953-2959.